论文部分内容阅读
目的对盐酸曲美他嗪治疗急性病毒性心肌炎患者所发挥的心肌保护作用进行探讨。方法 68例急性病毒性心肌炎患者,按随机数字法分为实验组和对照组,各34例。实验组采用盐酸曲美他嗪治疗,对照组采用常规治疗。比较两组治疗效果、肌钙蛋白I(c Tn I)以及肌酸激酶同工酶(CKMB)、乳酸脱氢酶(LDH)、肌酸激酶(CK)。结果实验组的治疗总有效率、LDH、CK-MB、CK以及c Tn I分别为97.06%、(164.5±36.4)U/L、(15.2±7.4)U/L、(125.4±36.7)U/L、(0.25±0.04)g/L,明显优于对照组的82.35%、(193.5±43.6)U/L、(20.3±9.3)U/L、(168.5±54.5)U/L、(0.42±0.09)g/L,差异具有统计学意义(P<0.05)。结论盐酸曲美他嗪治疗可提升急性病毒性心肌炎患者治疗效果,能够显著改善c Tn I、LDH、CK-MB、CK等指标,临床应用价值极高。
Objective To investigate the myocardial protective effect of trimetazidine hydrochloride in patients with acute viral myocarditis. Methods Sixty-eight patients with acute viral myocarditis were randomly divided into experimental group and control group with 34 cases in each group. The experimental group was treated with trimetazidine hydrochloride, while the control group was treated with conventional therapy. The therapeutic effects, cTn I and CKMB, LDH and CK were compared between the two groups. Results The total effective rate of the treatment group was 97.06%, (164.5 ± 36.4) U / L, (15.2 ± 7.4) U / L and (125.4 ± 36.7) U / L, (0.25 ± 0.04) g / L, which was significantly better than that of the control group (82.35%, 193.5 ± 43.6 U / L, 20.3 ± 9.3 U / L, 168.5 ± 54.5 U / L, 0.09) g / L, the difference was statistically significant (P <0.05). Conclusion Trimetazidine hydrochloride treatment can improve the therapeutic effect of patients with acute viral myocarditis, and can significantly improve cTn I, LDH, CK-MB, CK and other indicators, the clinical value is extremely high.